Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetVivo HoldingsPETV +3.00%35 EV-to-EBITDA is -2.73 as of Jul. 29, 2026. GuruFocus rates PETV with a GF Score™ of 35/100 and a GF Value™ of $0.50 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 512 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PetVivo Holdings's enterprise value is $24.18 Mil.
PetVivo Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.87 Mil. Therefore, PetVivo Holdings's EV-to-EBITDA for today is -2.73.
The historical rank and industry rank for PetVivo Holdings's EV-to-EBITDA or its related term are showing as below:
PETV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -51.02 Med: -3.55 Max: -0.21
Current: -2.73
During the past 13 years, the highest EV-to-EBITDA of PetVivo Holdings was -0.21. The lowest was -51.02. And the median was -3.55.
PETV's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.25
vs PETV: -2.73
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PetVivo Holdings's PE Ratio (TTM) for today is calculated as:
PetVivo Holdings's share price for today is $0.6423.
PetVivo Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for PetVivo Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PetVivo Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's EV-to-EBITDA falls into.
PetVivo Holdings's current Enterprise Value is $24.18 Mil.
PetVivo Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (PETV) has a EV-to-EBITDA of -2.73 as of Jul. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PetVivo Holdings. According to the industry distribution chart, PetVivo Holdings ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is PetVivo Holdings' EV-to-EBITDA too high?
PetVivo Holdings' current EV-to-EBITDA is -2.73. Based on the distribution chart, PetVivo Holdings ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 35/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' EV-to-EBITDA compare to FOFA and ARAY?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #999999 out of 512 companies for EV-to-EBITDA. This places PetVivo Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 14.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.25, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PetVivo Holdings. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current EV-to-EBITDA is -2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.50, compared to a current price of $0.64 — trading 28.5% above its estimated fair value. The current EV-to-EBITDA is -2.73. PetVivo Holdings' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current EV-to-EBITDA is -2.73 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetVivo Holdings (PETV) Overvalued in 2026?
Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued.
The current stock price of $0.64 is trading 28.5% above its estimated GF Value™ of $0.50.
GuruFocus considers PetVivo Holdings to be Modestly Overvalued.
Key valuation signals for PETV:
EV-to-EBITDA: -2.73
GF Value™: $0.50 vs. price of $0.64 (28.5% above fair value)
No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
35GF Score
Get the complete analysis for PETV
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETV has been successfully added to your 
